| Literature DB >> 28081721 |
Alexander Liu1, Rohan S Wijesurendra1, Rina Ariga1, Masliza Mahmod1, Eylem Levelt1, Andreas Greiser2, Mario Petrou3, George Krasopoulos3, John C Forfar4, Rajesh K Kharbanda4,5, Keith M Channon5, Stefan Neubauer1, Stefan K Piechnik1, Vanessa M Ferreira6.
Abstract
BACKGROUND: Perfusion cardiovascular magnetic resonance (CMR) performed with inadequate adenosine stress leads to false-negative results and suboptimal clinical management. The recently proposed marker of adequate stress, the "splenic switch-off" sign, detects splenic blood flow attenuation during stress perfusion (spleen appears dark), but can only be assessed after gadolinium first-pass, when it is too late to optimize the stress response. Reduction in splenic blood volume during adenosine stress is expected to shorten native splenic T1, which may predict splenic switch-off without the need for gadolinium.Entities:
Keywords: Adenosine stress; Cardiovascular magnetic resonance; ShMOLLI; Splenic T1; Switch-off
Mesh:
Substances:
Year: 2017 PMID: 28081721 PMCID: PMC5234250 DOI: 10.1186/s12968-016-0318-2
Source DB: PubMed Journal: J Cardiovasc Magn Reson ISSN: 1097-6647 Impact factor: 5.364
Fig. 1Representative stress and rest splenic first-pass gadolinium perfusion and native T1-maps. Signal intensity (SI) curves represent splenic perfusion SI (y-axis, arbitrary units) over time (x-axis, 50–60 s). The maximum and minimum SIspleen are as indicated. Splenic regions of interests on perfusion images and T1-maps are outlined in red and black, respectively. Mean native T1spleen and stress changes (ΔT1 ) are as labelled. 3 T images were used for illustration (observed ΔT1 and ΔSI are field strength independent)
Characteristics of study subjects: healthy controls and patients (n = 212)
| 1.5 T | 1.5 T | 3 T | 3 T | |
|---|---|---|---|---|
| Age (years) | 54 ± 17 | 65 ± 9* | 43 ± 12 | 60 ± 14* |
| Men (%) | 21 (72) | 58 (77) | 13 (59) | 58 (67) |
| Body mass index (kg/m2) | 25 ± 4 | 28 ± 5 | 26 ± 3 | 28 ± 4 |
| Hematocrit | 0.42 ± 0.03 | 0.43 ± 0.03 | 0.42 ± 0.04 | 0.42 ± 0.03 |
| CMR hemodynamic data | ||||
| Rest HR (bpm) | 66 ± 11 | 62 ± 15 | 62 ± 12 | 65 ± 10 |
| Stress HR (bpm) | 96 ± 15 | 79 ± 15* | 95 ± 12 | 91 ± 14 |
| Rest SBP (mmHg) | 133 ± 21 | 139 ± 19 | 127 ± 14 | 136 ± 19 |
| Stress SBP (mmHg) | 127 ± 19 | 133 ± 19 | 122 ± 16 | 126 ± 19 |
| Rest RPP (bpm.mmHg) | 8800 ± 2200 | 8600 ± 2200 | 7600 ± 1700 | 8700 ± 2000 |
| Stress RPP (bpm.mmHg) | 12,200 ± 2600 | 10,500 ± 2500* | 12,000 ± 2200 | 11,700 ± 2700 |
| Adenosine symptoms | 29 (100) | 75 (100) | 22 (100) | 86 (100) |
| Co-morbidities | ||||
| Current smoker | 3 (10) | 2 (3) | 2 (9) | 12 (14) |
| Ex-smoker | 3 (10) | 21 (28) | 3 (14) | 21 (24) |
| Hypertension | - | 28 (37) | - | 24 (28) |
| Hyperlipidemia | - | 23 (31) | - | 23 (27) |
| Stroke/TIA | - | 2 (3) | - | 2 (2) |
| Medications | ||||
| Aspirin | - | 36 (48) | - | 35 (41) |
| Beta-blocker | - | 34 (45)# | - | 19 (22) |
| ACEi/ARB | - | 36 (48) | - | 39 (45) |
| Statin | - | 31 (41)# | - | 44 (51) |
| Nitrates | - | 3 (4) | 4 (5) | |
| CCB (non-DHP) | - | 13 (17)# | - | 0 (0) |
| CCB (DHP) | 4 (5) | 7 (8) |
Values are n (%) or mean ± SD
Abbreviations: RPP rate pressure product, TIA transient ischemic attack, ACEi angiotensin-converting enzyme inhibitors, ARB angiotensin receptor blockers, CCB calcium channel antagonist, DHP dihydropyridine
*p < 0.05 compared to controls of corresponding field strength (1.5 T or 3 T). # p < 0.05 for comparisons between patient groups (1.5 T vs 3 T)
Rest and stress splenic T1 in healthy controls and patients
| 1.5 T Controls | 1.5 T Patients |
| 3 T Controls | 3 T |
| |
|---|---|---|---|---|---|---|
| Rest T1spleen (ms) | 1102 ± 66 | 1083 ± 59 | 0.04 | 1352 ± 114 | 1295 ± 105 | 0.01 |
| Stress T1spleen (ms) | 1061 ± 68 | 1039 ± 55 | 0.02 | 1308 ± 114 | 1253 ± 112 | 0.01 |
| ΔT1spleen (ms) | −40 ± 25 | −44 ± 21 | 0.43 | −43 ± 31 | −44 ± 26 | 0.93 |
ΔT1spleen = StressT1spleen – RestT1spleen
Peak splenic perfusion signal intensity (SIspleen) at rest and during adenosine stress (ΔSIspleen) in healthy controls and patients
| 1.5 T | 1.5 T Patients | 3 T Controls | 3 T Patients |
| |
|---|---|---|---|---|---|
| Rest SIspleen (au) | 26 ± 8 | 24 ± 11 | 29 ± 13 | 27 ± 13 | 0.16 |
| Stress SIspleen (au) | 11 ± 5 | 11 ± 5 | 13 ± 12 | 12 ± 8 | 0.10 |
| ΔSIspleen (%) | −58 ± 23 | −54 ± 22 | −56 ± 28 | −52 ± 30 | 0.51 |
Abbreviations: Au arbitrary units
P-values derived using ANOVA with Bonferroni post-hoc method
Fig. 2Correlation between stress-induced reductions in peak splenic signal intensity (ΔSI ) and splenic native T1 (ΔT1 ). Pooled data of controls and patients at 1.5 T (blue) and 3 T (red), represented on per-subject basis (n = 212). Spearman’s rank correlation coefficient (Rho) = 0.70, p < 0.0001
Stress-induced changes in peak splenic perfusion signal intensity (ΔSIspleen), T1 (ΔT1spleen) and hemodynamic parameters for visually assessed “splenic switch-off” sign
| Splenic Switch-off | No |
| |
|---|---|---|---|
| All subjects | 196 (92) | 16 (8) | - |
| Healthy volunteers | 49 (96) | 2 (4) | - |
| Patients | 147 (91) | 14 (9) | - |
| ΔSIspleen (%) | −62 ± 17 | 17 ± 29 | <0.0001 |
| ΔT1spleen (ms) | −46 ± 22 | −2 ± 25 | <0.0001 |
| Stress hemodynamic changes | |||
| Δ heart rate (bpm) | 19 ± 9 | 20 ± 12 | 0.83 |
| Δ SBP (mm. Hg) | −8 ± 22 | −10 ± 19 | 0.76 |
| Δ RPP (bpm.mmHg) | 2800 ± 2100 | 2600 ± 1700 | 0.89 |
Values are n (%) or mean ± SD
Abbreviations: Bpm beats per minute, SBP systolic blood pressure, RPP rate pressure product
Fig. 3Relations between different markers of stress adequacy. Subjects with the “splenic switch-off” sign had greater stress-induced reductions in a gadolinium-based splenic perfusion (ΔSIspleen, same technique) and b gadolinium-free splenic T1 (ΔT1spleen, different technique) compared to subjects with no switch-off. There was no difference in stress-induced c hemodynamic changes in rate pressure product (RPP) between the splenic switch-off and the no switch-off subjects. Data are mean ± 1SD
Fig. 4ROC curves of native ΔT1spleen for replicating the gadolinium-based “splenic switch-off” sign. A ΔT1spleen threshold of ≥ −30 ms replicated the “splenic switch-off” sign (AUC 0.90 ± 0.05, p < 0.0001), with high sensitivity 90%, specificity 88% and diagnostic accuracy 90%
Fig. 5Potential splenic ΔT1spleen-guided protocol for real-time assessment and optimization of stress adequacy before gadolinium perfusion. Practical T1spleen assessment using ShMOLLI typically takes around 30 s: breath-hold instructions (5 s), T1-map acquisition over 9-heart-beats (~10 s, shorter with higher stress heart rates), on-screen image reconstruction (5–10 s), splenic-ROI placement directly on CMR console screen by the operator (5 s) followed by immediate display of T1spleen/SD estimations (as indicated). The ability of this protocol to improve the quality of stress responses deserves validation in future studies